ProCE Banner Activity

Importance of Personalized and Multimodal Treatment: Key Insights From Recent Expert Presentations

Clinical Thought

An expert synthesizes key insights from recent presentations on the importance of a personalized and multimodal treatment approach for major depressive disorder and treatment-resistant depression. 

Released: November 12, 2024

Expiration: November 11, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.

AbbVie Inc.

Intra-Cellular Therapies, Inc.

Disclosure

Primary Author

Lisa Harding, MD

Assistant Clinical Professor of Psychiatry
Yale School of Medicine
Medical Director, Mood Institute
Milford, Connecticut

Lisa Harding, MD: consultant/advisor/speaker: Compass Pathways, Janssen Scientific Affairs, Otsuka.